첫 페이지 News 본문

According to the AI news, Lilly's stock price surged 10% before the US stock market, as the trial results of its weight loss drug competitor Novo Nordisk CagriSema fell short of expectations. Novo Nordisk's stock price, trading in Europe, plummeted by 28%.
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

胡胡胡美丽_ss 注册会员
  • Follow

    0

  • Following

    0

  • Articles

    34